Previous 10 | Next 10 |
home / stock / aps:cc / aps:cc news
A look at the top 10 most actives in Canada Baytex Energy Corp. (BTE) rose 2.7% to $4.305 on volume of 11,390,074 shares Argonaut Gold Inc. (AR) rose 22.0% to $0.305 on volume of 11,228,830 shares Bitfarms Ltd. (BITF) rose 6.2% to $3.58 on volume of 9,336,087 shares Cenovus Energy Inc. ...
SAN DIEGO and TORONTO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (Nasdaq: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated targeted agents to treat hematologic malignancie...
2024-01-26 16:40:00 ET The S&P/TSX Composite Index rose 75 points on Thursday, January 25, 2024. Some of the top-performing sectors included energy, utilities, and battery metals. Today, I want to focus on three of the worst-performing equities to close out 2023. Are these reeling ...
SAN DIEGO and TORONTO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (Nasdaq: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated targeted agents to treat hematologic malignancies, t...
Reporting Complete Response Data from the Ongoing APTIVATE International Phase 1/2 Study of Tuspetinib (TUS) in Relapsed/Refractory AML Patients TUS Single Agent and TUS/VEN Combination Demonstrate Favorable Safety and Tolerability TUS/VEN Combination Active Across Broad P...
SAN DIEGO and TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, t...
Tuspetinib (TUS) Targets Venetoclax (VEN) Resistance Mechanisms TUS/VEN Combination Therapy Active in R/R VEN Failure AML Patients – Guides Toward Accelerated Approval Path, Including FLT3 Mutated and Wildtype TUS/VEN Overall Response Rate of 48% in Heavily Pre-Trea...
K-Bro Linen Inc. (KBL:CA) is expected to report $0.57 for Q3 2023 Yellow Pages Limited (Y:CA) is expected to report for Q3 2023 Ascot Resources Ltd. (AOT:CA) is expected to report for Q3 2023 Park Lawn Corporation (PLC:CA) is expected to report $0.27 for Q3 2023 Hut 8 Mining Corp....
Aptose Biosciences Inc. (APS:CA) is expected to report $-2.92 for Q3 2023
SAN DIEGO and TORONTO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated targeted agents to treat hematologic malignancies, t...
News, Short Squeeze, Breakout and More Instantly...
Aptose Biosciences Inc. Company Name:
APS:CC Stock Symbol:
TSXC Market:
Aptose Biosciences Inc. Website:
SAN DIEGO and TORONTO, July 19, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, t...
A look at the top 10 most actives in Canada BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 11.1% to $2.63 on volume of 13,371,978 shares Baytex Energy Corp. (BTE) fell 1.4% to $5.08 on volume of 13,132,263 shares Enbridge Inc. (ENB) rose 0.7% to $49.58 on volume of 10,761,843 sha...
A look at the top 10 most actives in Canada Calibre Mining Corp. (CXB) fell 2.9% to $1.835 on volume of 79,684,444 shares Canadian Natural Resources Limited (CNQ) rose 1.6% to $48 on volume of 6,456,525 shares Alaris Equity Partners Income Trust 5.50% convertible unsecured subordinated de...